NCT02972268

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH

Clinical Trial to Compare the Efficacy and Safety of Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 780 (actual)
• Sponsor: Jeil Pharmaceutical Co., Ltd. · Industry
• Sex: Male
• Age: 45 Years
• Healthy volunteers: Not accepted

Summary

Clinical Trial to Compare the Efficacy and Safety of Solifenacin/Tamsulosin Combination Therapy with Tamsulosin Monotherapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia

Conditions

• Lower Urinary Tract Symptoms
• Benign Prostatic Hyperplasia

Interventions

Type	Name	Description
DRUG	Tamsulosin 0.2mg + Solifenacin 5mg	Tamsulosin 0.2mg + Solifenacin 5mg for 12wks
DRUG	Tamsulosin 0.2mg + Placebo(Solifenacin)	Tamsulosin 0.2mg + Placebo(Solifenacin) for 12wks

Timeline

• Start date: 2016-02-01
• Primary completion: 2017-11-02
• Completion: 2018-08-14
• First posted: 2016-11-23
• Last updated: 2019-08-29

Locations

1 site across 1 country: South Korea